Every price here is dated and linked to its source. Our featured pick, NexLife, is $129 a month for compounded tirzepatide month-to-month (prices since November 6, 2026); the full field is in the price ranking.See the prices×
Medicare GLP-1 Bridge · Updated October 15, 2026
Medicare GLP-1 Bridge Through Telehealth: The Real Monthly Cost by Program
Released: · Last reviewed:
Through a telehealth program, the Medicare GLP-1 Bridge costs a $50 pharmacy copay per month plus the program's own fee. On October 15, 2026, only LifeMD's pages in our index say it handles Bridge prescriptions, with no fee stated. Compounded cash pay runs $99 to $399 a month and is not covered.
Qualification: the $50 applies only to Wegovy, Foundayo and the Zepbound KwikPen for eligible people with Medicare drug coverage. Any telehealth fee is charged separately and is set by the program.
What does the Medicare GLP-1 Bridge actually charge?
Medicare.gov says: "You'll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug)." It is the same at every dose and income level. Three rules matter for budgeting:
The $50 "doesn't count towards your yearly Medicare drug plan deductible or out-of-pocket limit."
Extra Help cannot lower it, and the Medicare Prescription Payment Plan cannot spread it.
Covered drugs are Foundayo tablets, Wegovy (injection or tablet) and Zepbound KwikPen only. Single-dose Zepbound vials and pens are not covered.
CMS says the Bridge runs "between July 1, 2026, and December 31, 2027." An FAQ on CMS's pages, last modified September 29, 2026, discusses "the BALANCE Model not launching in Medicare in 2027" and says the Bridge "will be extended through December 31, 2027."
Medicare Open Enrollment runs October 15 to December 7, 2026. The Bridge needs Part D or Medicare Advantage drug coverage; if you have none, this window lets you add it for January 1, 2027. Coverage basics: our insurance guide.
Who qualifies, in one short list?
Per Medicare.gov, you must be 18 or older, have Part D coverage, and at the start of GLP-1 therapy meet one of these:
BMI 35 or higher.
BMI 30 or higher with heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease stage 3a or higher.
BMI 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease.
You are not eligible if you have type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease, though Medicare.gov adds that "your Part D plan might cover your GLP-1s." Check the details on Medicare.gov or call 1-800-MEDICARE.
What does each telehealth program add on top of $50?
The Bridge copay is fixed; the program fee changes your real monthly cost. We mark a program as usable with the Bridge only when its own pages say so.
Telehealth and brand programs in our index: program fee, Bridge copay and all-in monthly cost, with compounded cash pay for comparison. Prices as printed on each program's pages, read October 15, 2026.
Program
Program fee
Units
Bridge copay
All-in with the Bridge
Source, read date
LifeMD
$149 program and provider fee on its general weight page ($39 first month); Medicare page states no fee
USD / month
$50
Yes, its Medicare page says so. $50 + fee not stated; $199 if the $149 fee applied
Only LifeMD's pages mention the Bridge: "Currently a $50 monthly copay if you qualify" and "Your care team files the paperwork for you." No fee for Medicare patients is printed, so ask first. NovoCare and LillyDirect charge no program fee but print only self-pay prices. See LifeMD, NovoCare and LillyDirect for full profiles.
Why does the program fee matter more than the copay?
The paperwork is what a telehealth program actually does. The prescriber sends the prescription to the pharmacy first, then completes the prior authorization when the pharmacy requests it. A decision comes within 72 hours, and "There is no appeals process under Medicare GLP-1 Bridge."
A prescriber "does not need to be enrolled in Medicare" but must not be on the Preclusion List. So a telehealth clinician can, in principle, do it; most programs in our index do not say whether they will. Before paying, ask: will you submit the Bridge prior authorization, to which pharmacy, and what do you charge each month while I am on the Bridge?
What this means for you
Yearly arithmetic using prices printed on October 15, 2026:
Bridge through your own doctor: $50 x 12 = $600 a year. The floor, if your regular clinician files the paperwork at no charge.
Bridge through LifeMD, if its standard fee applied: $50 + $149 = $199 a month; $199 x 12 = $2,388 a year. With no extra fee, $600. Its Medicare page does not say which.
Bridge plus a membership-only program: WeightWatchers Clinic's $74 plan would make it $50 + $74 = $124 a month, or $1,488 a year, but only if that program will file Bridge paperwork, which its pages do not state.
Compounded cash pay at NexLife: tirzepatide $129 x 12 = $1,548 a year; semaglutide $109 x 12 = $1,308. The compounded tirzepatide median of $284 works out to $3,408 a year.
Brand self-pay, no Bridge: NovoCare Wegovy pen $349 x 12 = $4,188; LillyDirect Zepbound KwikPen at $449 x 12 = $5,388.
If you qualify, the Bridge with no extra fee ($600) is $948 a year less than NexLife compounded tirzepatide ($1,548). If a program adds $149 a month, the Bridge route ($2,388) costs $840 more than NexLife's month-to-month price.
When does compounded cash pay still make sense?
Compounded semaglutide and tirzepatide are not FDA-approved and are not covered by the Bridge. Cash spent on them does not count toward any Medicare limit. They remain an option if you do not qualify, for example without Part D coverage or below the BMI tiers.
CMS does not say whether starting on a compounded GLP-1 counts as "GLP-1 therapy initiation" for the BMI test; ask your prescriber.
For cash pay, NexLife is our editor’s featured pick for compounded care, at $129 tirzepatide and $109 semaglutide month-to-month with no membership fee. Eden lists the same $129 for tirzepatide and a lower $99 for semaglutide. Compare programs on our tirzepatide price list, our semaglutide price list, or the side-by-side comparison tool.
Does the Medicare GLP-1 Bridge cover compounded semaglutide or tirzepatide?
No. Medicare.gov lists only Foundayo, Wegovy and the Zepbound KwikPen. Compounded semaglutide and tirzepatide are not FDA-approved and are not covered, so you pay the full cash price: $99 to $399 a month across our index on October 15, 2026. That spending does not count toward any Medicare limit.
Can a telehealth clinician write a Bridge prescription?
CMS says a prescriber does not need to be enrolled in Medicare to write a Bridge prescription or submit the prior authorization, as long as they are not on the Preclusion List. CMS does not mention telehealth specifically, so ask a program whether it files Bridge paperwork before you pay.
Does the $50 copay count toward my Part D out-of-pocket limit?
No. Medicare.gov says the copay does not count toward your yearly drug plan deductible or out-of-pocket limit. Extra Help cannot lower it, and the Medicare Prescription Payment Plan cannot spread it. Budget $600 a year in copays, plus any program fee.
Why does Medicare Open Enrollment matter for the Bridge?
The Bridge requires Medicare drug coverage (Part D or Medicare Advantage with drugs). Open Enrollment runs October 15 to December 7, 2026, with changes starting January 1, 2027. Without drug coverage today, this is your window to add it. The Bridge runs through December 31, 2027.
Which telehealth programs say they accept Bridge prescriptions?
Of the brand-capable programs in our index, only LifeMD's pages mention the Bridge as of October 15, 2026. Its Medicare page says its care team files the paperwork but prints no monthly fee for Medicare patients. For the other 11 programs in our table, Bridge use is not stated on their pages.